SAHPRA reviews the use of ivermectin to treat covid 19

South African Health Products Regulatory Authority (SAHPRA) says it has now reviewed again, the available data from clinical studies. The authority says it encourages the submission of clinical trial applications designed to establish the safety and efficacy of ivermectin in the management of Covid-19 infections for both treatment and prophylaxis and commits to expediting their review….We spoke to Professor Helen Rees- Executive Director of the Wits Reproductive Health and HIV Institute and Chairman of the South African Health Products Regulatory Authority…